G

GeNeuro SA

19 employees

GeNeuro is a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases.

Basic info

Industry

biotechnology research

Sectors

HERV
Multiple Sclerosis
Biotechnology
Health Care
Therapeutics
ALS
SLA
Autoimmune diseases
Progressive MS

Date founded

2006

Funding rounds raised

Total raised

$8M

from 3 investors over 3 rounds

G

GeNeuro SA raised $7.5M on March 7, 2023

Investors: European Investment Bank

G

GeNeuro SA raised $8M on May 12, 2022

Investors: INSTITUT MÉRIEUX

G

GeNeuro SA raised $7.3M on December 13, 2021

Investors: Bundesamt für Gesundheit

FAQ